Market Movers – Feb. 2021
Price action in energy markets benefited most CTA strategies and was a major catalyst for positive performance in February. Two primary drivers of the energy trade emerged in February, one which has been a steady drumbeat behind the market in recent months, while the other was much more specific and acute.
First, continued optimism over economic reopening has seen increased demand for commodities, with energy being one of the main beneficiaries. COVID-19 vaccine doses administered surpassed the number of confirmed COVID-19 cases in the first week of February, providing further support that the vaccine is being implemented effectively in certain parts of the globe and a return to normalcy is closer than we previously thought.
The second component to the energy trade was the so-called “Texas Freeze.” In mid-February, Texas and other states along the Gulf Coast experienced unprecedented freezing temperatures that disrupted the energy supply chain, causing electricity prices to rise exponentially. Most strategy types were able to benefit from the supply shock as wells and refineries had to cease operating due to the frigid temperatures. Although energy markets have retraced some of the February gains, the long-term outlook for the energy markets remains strong; we hope to see managers continue to profit from increased demand as global economies reopen.
To send a question to the author, or to learn more about this topic, click here.
For more information about Coquest Advisors and its Portfolios, please click here.
Disclosure: The risk of loss in trading futures and/or options is substantial. Past performance is not indicative of future results. The information in this message derived from third-party sources is believed to be accurate and reliable; Coquest does not guarantee the accuracy or completeness of the information. Opinions expressed in this material are subject to change without notice. This report should not be interpreted as a request to engage in any transaction of futures, options, and/or OTC derivatives. The information contained in this material is not to be relied upon in substitution for the exercise of your independent judgment. Seek independent financial, tax, legal, and accounting advice from your own professional advisers, based upon your particular circumstances.Back